Kimball Electronics, Inc. Reports First Quarter Fiscal Year 2021 Results

• Net sales in the first quarter were $332 million, a new quarterly record, up 6% year-over-year
• Quarterly records for operating income of $17.8 million, net income of $16.8 million, and diluted earnings per share of $0.66
• First quarter operating income of 5.4% as a percent of net sales
• Strong cash flows provided by operating activities of $20.7 million during the first quarter

JASPER, Ind., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Kimball Electronics, Inc. (Nasdaq: KE) today announced financial results for the first quarter ended September 30, 2020. 

(1)  A reconciliation of GAAP and non-GAAP financial measures is included below. 

(2)  Beginning in the first quarter of fiscal year 2021, adjusted operating income excludes changes in the fair value of our supplemental employee retirement plan, or SERP, liability which are exactly offset by the revaluation to fair value of the SERP investments in Other Income (Expense), net, and as a result have no impact on net income.  Prior reported periods have been revised accordingly.

Donald D. Charron, Chairman and Chief Executive Officer, stated, “We are very pleased with the operating results we delivered in the first quarter of fiscal year 2021.  We set new quarterly records for sales as well as operating income, net income, and diluted EPS, while generating strong cash flow from operations for the second consecutive quarter.  Our sales in our medical vertical increased 25% compared to the first quarter of fiscal year 2020 and were up 3% sequentially for a new quarterly record.  We expect the sales in our medical vertical to normalize and begin to approximate pre-COVID-19 run rates during the second quarter of fiscal year 2021.  Sales in our automotive vertical continued to gain momentum during the first quarter of fiscal year 2021 increasing 61% from the previous quarter and down just 5% from the first quarter of fiscal year 2020.  We expect the sales in our automotive vertical will return to pre-COVID-19 levels in the second quarter and steadily increase throughout fiscal year 2021.”

Mr. Charron continued, “Beyond our excellent financial results, we never lost sight of the fact that the health and safety of our employees remains our number one priority, and we continue to make every effort to keep our facilities safe.  The number of our employees testing positive for COVID-19 has been kept at a low level and disruptions have been kept to a minimum.  Because of the disciplined response and extraordinary effort of our people around the world, we were able to perform our mission as an “essential business” and support the significant increases from our medical customers for their respiratory care and patient monitoring products.”

First Quarter Fiscal Year 2021 Overview:

• Consolidated net sales increased 6% compared to the first quarter of fiscal year 2020.  Foreign currency had a favorable 1% impact on net sales in the current quarter compared to the same period a year ago.
• Operating activities provided cash of $20.7 million during the quarter, which compares to cash provided by operating activities of $39.6 million in the first quarter of fiscal year 2020.
• Cash conversion days (“CCD”) for the quarter ended September 30, 2020 were 76 days, down from 81 days in the fourth quarter of fiscal year 2020 and up from 73 days for the quarter ended September 30, 2019.  CCD is calculated as the sum of days sales outstanding plus contract asset days plus production days supply on hand less accounts payable days.
• Investments in capital expenditures were $8.5 million during the quarter.
• Cash and cash equivalents were $73.4 million and borrowings outstanding on credit facilities were $110.5 million at September 30, 2020, including $91.5 million classified as long term.

Net Sales by Vertical Market:

Forward-Looking Statements
Certain statements contained within this release are considered forward-looking under the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties including, but not limited to, successful integration of acquisitions, ramp up of new operations, global economic conditions, geopolitical environment, global health emergencies including the COVID-19 pandemic, significant volume reductions from key contract customers, loss of key customers or suppliers, financial stability of key customers and suppliers, availability or cost of raw materials, the ability of the supply chain to react successfully to the significant increase in demand for certain medical components, impact related to tariffs and other trade barriers, and increased competitive pricing pressures.  Additional cautionary statements regarding other risk factors that could have an effect on the future performance of the Company are contained in its Annual Report on Form 10-K for the year ended June 30, 2020. 

Non-GAAP Financial Measures
This press release contains non-GAAP financial measures.  A non-GAAP financial measure is a numerical measure of a company’s financial performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with Generally Accepted Accounting Principles (“GAAP”) in the United States in the statement of income, statement of comprehensive income, balance sheet, statement of cash flows, or statement of share owners’ equity of the Company.  The non-GAAP financial measures contained herein include adjusted operating income, adjusted net income, and adjusted diluted EPS.  These measures include adjustments for the three months ended September 30, 2020 for proceeds from lawsuit settlements.  For all periods presented, adjusted operating income excludes changes in the fair value of our SERP liability.  Reconciliations of the reported GAAP numbers to these non-GAAP financial measures are included in the Reconciliation of Non-GAAP Financial Measures section below.  Management believes it is useful for investors to understand how its core operations performed without the effects of proceeds from lawsuit settlements and changes in the fair value of our SERP liability.  Excluding these amounts allows investors to meaningfully trend, analyze, and benchmark the performance of the Company’s core operations.

For those unable to participate in the live webcast, the call will be archived at investors.kimballelectronics.com.

About Kimball Electronics, Inc.
Kimball Electronics is a multifaceted manufacturing solutions provider of electronics and diversified contract manufacturing services to customers around the world.  From our operations in the United States, China, India, Japan, Mexico, Poland, Romania, Thailand, and Vietnam, our teams are proud to provide manufacturing services for a variety of industries.  Recognized for a reputation of excellence, we are committed to a high-performance culture that values personal and organizational commitment to quality, reliability, value, speed, and ethical behavior.  Kimball Electronics, Inc. (Nasdaq: KE) is headquartered in Jasper, Indiana.

To learn more about Kimball Electronics, visit: www.kimballelectronics.com.

Lasting relationships. Global success.

Financial highlights for the first quarter ended September 30, 2020 are as follows:

(1)  Beginning in the first quarter of fiscal year 2021, adjusted operating income excludes changes in the fair value of our supplemental employee retirement plan, or SERP, liability which are exactly offset by the revaluation of the fair value of the SERP investments in Other Income (Expense), net, and as a result have no impact on net income.  Prior reported periods have been revised accordingly.

CONTACT:
Adam W. Smith
Treasurer
Telephone: 812.634.4000
E-mail: Investor.Relations@kimballelectronics.com